Jw. Kupiecweglinski et al., CD4 MAB THERAPY MODULATES ALLOANTIBODY PRODUCTION AND INTRACARDIAC GRAFT DEPOSITION IN ASSOCIATION WITH SELECTIVE-INHIBITION OF TH1 LYMPHOKINES, The Journal of immunology, 151(9), 1993, pp. 5053-5061
The accelerated (24 h) rejection of (LEWxBN)F1 cardiac allografts (Tx)
in LEW rats sensitized with BN skin grafts, is abrogated with CD4 mAb
(BWH-4) administration between skin (day-7) and heart (day 0) transpl
antation (Tx survival ca. 11 days, p < 0.0001). This study analyzed th
e effects of CD4-targeted therapy upon host IgG and IgM alloantibody (
allo-Ab) within the serum by two-color flow cytometry, and within the
Tx, by immunohistology. These data were correlated with mRNA and prote
in production profiles of Th1 (IL-2, IFN-gamma) vs Th2 (IL-4) specific
cytokines (polymerase chain reaction and/or immunohistology). Skin gr
afts elicited a strong systemic IgM allo-Ab response, which peaked at
the time of cardiac Tx rejection at 24 h. It was associated with exten
sive deposits of IgM on Tx endothelium. Treatment with BWH-4 mAb dimin
ished circulating IgM allo-Ab levels, and only low levels of IgM could
be detected at the Tx site. Conversely, the low circulating IgG allo-
Ab levels during rejection at 24 h in untreated recipients were accomp
anied by a strong labeling for intra-Tx IgG. BWH-4 mAb therapy did not
prevent totally the switch of the IgM to IgG, but the IgG allo-Ab res
ponse was earlier, less intense and more transient than in untreated r
ecipients. Accelerated rejection triggered sequential lymphokine mRNA
expression in cardiac Tx, with the peak of transcription for IL-2 (6-1
2 h) preceding that for IL-4 (24 h). Interestingly, although CD4 targe
ted therapy virtually ablated the induction of IL-2 mRNA, it preserved
transcription of the IL-4 gene. BWH-4 mAb therapy decreased otherwise
abundant intra-Tx IL-2 and IFN-gamma, but allowed a vigorous elaborat
ion of IL-4, confirming the translation of mRNA to the protein in vivo
. Thus, CD4 mAb-mediated abrogation of accelerated cardiac Tx injury c
orrelates with suppression of Th1 responses (depressed IL-2 and IFN-ga
mma production), but sparing of the Th2 function (enhanced IL-4 elabor
ation). Indeed, CD4 mAb-induced allo-Ab depression and immunosuppressi
ve effects may reflect selective targeting of proinflammatory Th1-like
cells and the multifaceted effects of IL-4 produced by unopposed Th2-
like cells.